Volltext-Downloads (blau) und Frontdoor-Views (grau)

Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-59402

Hemodialysis and Plasma Oxylipin Biotransformation in Peripheral Tissue

  • Factors causing the increased cardiovascular morbidity and mortality in hemodialysis (HD) patients are largely unknown. Oxylipins are a superclass of lipid mediators with potent bioactivities produced from oxygenation of polyunsaturated fatty acids. We previously assessed the impact of HD on oxylipins in arterial blood plasma and found that HD increases several oxylipins. To study the phenomenon further, we now evaluated the differences in arterial and venous blood oxylipins from patients undergoing HD. We collected arterial and venous blood samples in upper extremities from 12 end-stage renal disease (ESRD) patients before and after HD and measured oxylipins in plasma by LC-MS/MS tandem mass spectrometry. Comparison between cytochrome P450 (CYP), lipoxygenase (LOX), and LOX/CYP ω/(ω-1)-hydroxylase metabolites levels from arterial and venous blood showed no arteriovenous differences before HD but revealed arteriovenous differences in several CYP metabolites immediately after HD. These changes were explained by metabolites in the venous blood stream of the upper limb. Decreased soluble epoxide hydrolase (sEH) activity contributed to the release and accumulation of the CYP metabolites. However, HD did not affect arteriovenous differences of the majority of LOX and LOX/CYP ω/(ω-1)-hydroxylase metabolites. The HD treatment itself causes changes in CYP epoxy metabolites that could have deleterious effects in the circulation.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar

Statistics

frontdoor_oas
Metadaten
Author: Tong Liu, Inci Dogan, Michael Rothe, Julius V. Kunz, Felix Knauf, Maik Gollasch, Friedrich C. Luft, Benjamin Gollasch
URN:urn:nbn:de:gbv:9-opus-59402
DOI:https://doi.org/10.3390/metabo12010034
ISSN:2218-1989
Parent Title (English):Metabolites
Publisher:MDPI
Place of publication:Basel
Editor: Manfredi Rizzo
Document Type:Article
Language:English
Date of first Publication:2022/01/04
Release Date:2022/07/05
Tag:arterio-venous; biotransformation; eicosanoids; erythrocyte; hemodialysis; lipidomics; oxylipins
GND Keyword:-
Volume:12
Article Number:34
Page Number:18
Faculties:Universitätsmedizin / Klinik und Poliklinik für Innere Medizin
Licence (German):License LogoCreative Commons - Namensnennung